Relay Therapeutics, Inc.
RLAY- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001812364
In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.
Politicians who traded RLAY
Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.
- Trades
- 1
- Filings
- 1
- Politicians
- 1
- Buys / sells
- 0 / 1
- Estimated volume
- $8.00K
- Sum of range midpoints
| Politician | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
 Daniel S. Goldman House · NY | 1 | 0 / 1 | $8.00K | Jul 12, 2023 | Aug 13, 2023 |
Trades
Reported trades in Relay Therapeutics, Inc., newest filings first.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.